Sort   by:  
 Page size 
UnknownOpen-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children.

Objectives

To evaluate a heterologous vaccination scheme in children 3-18 years old (y/o) combining two SARS-CoV-2r- receptor binding domain (RBD)protein vaccines.

Methods

A phase I/II open-label, adaptive, and multicenter trial evaluated the safety and immunogenicity of two doses of ...
S-EPMC9673084 | biostudies-literature
UnknownA snapshot of antimicrobial resistance in Mexico. Results from 47 centers from 20 states during a six-month period.
AIM:We aimed to assess the resistance rates of antimicrobial-resistant, in bacterial pathogens of epidemiological importance in 47 Mexican centers. MATERIAL AND METHODS:In this retrospective study, we included a stratified sample of 47 centers, covering 20 Mexican states. Selected isolates considere...
S-EPMC6435111 | biostudies-literature
Sort   by:  
 Page size